Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Rilzabrutinib for Adults with Relapsed Immune Thrombocytopenia
The NetherlandsStudy Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases
The NetherlandsStudy on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension
The NetherlandsStudy of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
The NetherlandsStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
The NetherlandsStudy of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)
The NetherlandsStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
The NetherlandsStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
The NetherlandsStudy of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer
The NetherlandsStudy on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
The NetherlandsLong-Term Safety Study of Riliprubart in Patients with Cold Agglutinin Disease
The NetherlandsStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Studies compare various treatment options to improve patient outcomes and survival rates.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.
Trials examine innovative treatment strategies and personalized approaches.
Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.
Research aims to improve treatment outcomes while minimizing toxicity.
Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.
Focus on improving surgical outcomes and treatment effectiveness.
Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.
Research aims to improve detection and treatment of brain metastases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
